autoimmune conference-coverage

Conference Coverage

Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA

01/03/2024

Priyam Vora, Associate Editor

Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.

Patients with psoriatic...

01/03/2024

Rheumatology & Arthritis

Conference Coverage

Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI

12/27/2023

Priyam Vora, Associate Editor

During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.

During her presentation on...

12/27/2023

Rheumatology & Arthritis

Conference Coverage

Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management

12/26/2023

Priyam Vora, Associate Editor

Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.

Patients with rheumatoid...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

Gregory McDermott, MD: Predictors of RA-ILD and Subtypes

12/26/2023

Priyam Vora, Associate Editor

Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.

Several factors have been shown...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

Breakthrough COVID-19 Infection Among RA Patients After Third Dose

12/26/2023

Priyam Vora, Associate Editor

In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.

In August 2021, the CDC...

12/26/2023

Rheumatology & Arthritis

Conference Coverage

This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients

12/20/2023

Priyam Vora, Associate Editor

Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.

Findings of an online survey...

12/20/2023

Rheumatology & Arthritis

Conference Coverage

Rheumatoid Arthritis and Long COVID—A Double Whammy

12/20/2023

Priyam Vora, Associate Editor

The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.

The increased odds of Long COVID...

12/20/2023

Rheumatology & Arthritis

Conference Coverage

Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial

12/12/2023

Priyam Vora, Associate Editor

The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.

The phase 3 SELECT-EARLY trial...

12/12/2023

Rheumatology & Arthritis

Conference Coverage

JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study

12/05/2023

Priyam Vora, Associate Editor

JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?

JAK inhibitors (JAKi) have been...

12/05/2023

Rheumatology & Arthritis

Conference Coverage

PsA and PsO Affecting Work Productivity?

11/20/2023

Priyam Vora, Associate Editor

Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.

Dr Nancy Shadick explains the...

11/20/2023

Rheumatology & Arthritis

Conference Coverage

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products